TWC
STIM icon

The Woodbridge Company’s Neuronetics STIM Stock Holding History

The Woodbridge Company’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,838
Closed -$2.54K – 67
2025
Q4 		$2.54K Hold
1,838
– – ﹤0.01% 76
2025
Q3 		$5.02K Hold
1,838
– – ﹤0.01% 33
2025
Q2 		$6.42K Buy
+1,838
New +$7.26K ﹤0.01% 32

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

The Woodbridge Company's STIM Position: Q1 2026 in Review

The Woodbridge Company sold out of Neuronetics (STIM) in Q1 2026, closing a stake of 1,838 shares — an estimated $2.54K sold.

The Woodbridge Company first reported a position in STIM in Q2 2025 and held it in 3 quarters. The position peaked at $6.42K in Q2 2025. 99 funds tracked by Wall St. Rank hold STIM as of Q1 2026.

  • The Woodbridge Company reported no remaining Neuronetics position as of Q1 2026 after selling out during the quarter.
  • The Woodbridge Company sold 1,838 Neuronetics shares in Q1 2026, an estimated $2.54K.
  • The Woodbridge Company first reported a position in Neuronetics in Q2 2025 and held it in 3 quarters.
  • The Woodbridge Company's Neuronetics position peaked at $6.42K in Q2 2025.
  • 99 funds tracked by Wall St. Rank held Neuronetics as of Q1 2026.

Based on The Woodbridge Company's 13F filing for Q1 2026, filed 14 May 2026.